| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/18/2003 | WO2003076646A2 Identification and tissue distribution of two novel spliced variants of the mouse lats2 gene |
| 09/18/2003 | WO2003076643A2 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections |
| 09/18/2003 | WO2003076631A2 Genetic products differentially expressed in tumors and use thereof |
| 09/18/2003 | WO2003076617A1 Transporter selectively transporting sulfate conjugate and its gene |
| 09/18/2003 | WO2003076603A2 Functionalization of t cell derived vesicles and use thereof for the preparation of immunogenic pharmaceutical compositions |
| 09/18/2003 | WO2003076602A2 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo |
| 09/18/2003 | WO2003076598A2 Method of inducing an enhanced immune response against hiv |
| 09/18/2003 | WO2003076591A2 Compositions and methods for generating an immune response |
| 09/18/2003 | WO2003076585A2 Controlled modulation of amino acid side chain length of peptide antigens |
| 09/18/2003 | WO2003076583A2 Genetically engineered phage and the use of genetically engineered phage to deliver nucleic acid to bacteria |
| 09/18/2003 | WO2003076579A2 Cancer-linked gene as target for chemotherapy |
| 09/18/2003 | WO2003076575A2 The complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof |
| 09/18/2003 | WO2003076571A2 Cancer-linked gene as target for chemotherapy |
| 09/18/2003 | WO2003076570A2 Antigens and their use as diagnostics and vaccines against species of plasmodium |
| 09/18/2003 | WO2003076569A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same |
| 09/18/2003 | WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase |
| 09/18/2003 | WO2003076473A1 Specific ab1'-antibodies against tumour-associated antigen ca 125 |
| 09/18/2003 | WO2003076470A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins |
| 09/18/2003 | WO2003076469A2 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature |
| 09/18/2003 | WO2003076455A2 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein |
| 09/18/2003 | WO2003075960A1 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 09/18/2003 | WO2003075957A1 The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents |
| 09/18/2003 | WO2003075956A2 Use of mixtures of lipopeptides for vaccine production |
| 09/18/2003 | WO2003075955A1 Method for enhancing immune responses by codelivering influenza np dna in dna immunization |
| 09/18/2003 | WO2003075954A1 Fuel additive |
| 09/18/2003 | WO2003075952A1 Methods of enhancing immune induction involving mda-7 |
| 09/18/2003 | WO2003075951A2 Novel application of vaccination against tnf-alpha |
| 09/18/2003 | WO2003075945A2 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| 09/18/2003 | WO2003075917A1 Combination therapy for treating, preventing or managing proliferative disorders and cancers |
| 09/18/2003 | WO2003075892A1 Pharmaceutical microparticles |
| 09/18/2003 | WO2003075849A2 Composition and method for enhancing immune response |
| 09/18/2003 | WO2003075845A2 Immunogenicity of glucan binding protein |
| 09/18/2003 | WO2003075843A2 Multiple and multivalent dna vaccines in ovo |
| 09/18/2003 | WO2003075841A2 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/18/2003 | WO2003075840A2 Human antibodies specific to kdr and uses thereof |
| 09/18/2003 | WO2003075831A2 NOVEL p53BP2 COMPOUNDS FOR THERAPY AND DIAGNOSIS AND METHODS FOR USING SAME |
| 09/18/2003 | WO2003075827A2 Use of mycobacterium w in the treatment of asthama(obstructive lung disease) |
| 09/18/2003 | WO2003075826A2 Process for manufacturing pharmaceutical composition comprises of mycobacterium w in the treatment of asthma(obstructive lung disease) |
| 09/18/2003 | WO2003075824A2 Process of manufacturing pharmaceutical composition useful for management of tuberculosis |
| 09/18/2003 | WO2003075741A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 09/18/2003 | WO2003068815A3 Mhc class ii peptide epitope of 5t4 antigen |
| 09/18/2003 | WO2003059252A3 Use of a novel cell surface protease from group b streptococcus |
| 09/18/2003 | WO2003057163A3 Methods for preparing immunoconjugates |
| 09/18/2003 | WO2003057130A3 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 09/18/2003 | WO2003054159A3 Modulating insulin receptor signaling through targeting facl |
| 09/18/2003 | WO2003046135A3 Osteopontin-related compositions and methods |
| 09/18/2003 | WO2003039595A3 Mucosal adjuvants comprising an oligonucleotide and a cationic lipid |
| 09/18/2003 | WO2003035105A3 A synthetic chimeric fusion protein with immuno-therapeutic uses |
| 09/18/2003 | WO2003024442A3 Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual disease |
| 09/18/2003 | WO2003022878A3 Subunit respiratory syncytial virus vaccine preparation |
| 09/18/2003 | WO2002102411A3 Method for treating psoriasis by using an il-17d antagonist |
| 09/18/2003 | WO2002100901A3 Determination of bone-sialoprotein in bodily fluids for oncological problems |
| 09/18/2003 | WO2002094868A3 Staphylococcus aureus proteins and nucleic acids |
| 09/18/2003 | WO2002092136A3 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy |
| 09/18/2003 | WO2002080982A3 Nucleic acid mucosal immunization |
| 09/18/2003 | WO2002077267A3 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
| 09/18/2003 | WO2002077174A3 Human cytokine receptor |
| 09/18/2003 | WO2002072790A3 Tsg101-gag interaction and use thereof |
| 09/18/2003 | WO2002059308A3 Method of diagnosing and treating cartilage disorders |
| 09/18/2003 | WO2002053177A3 Agents and methods for treating pain |
| 09/18/2003 | WO2002036625A9 Prokineticin polypeptides, related compositions and methods |
| 09/18/2003 | WO2002032455A3 Vaccine |
| 09/18/2003 | WO2002031181A3 Flea synaptic vesicle nucleic acid molecules, proteins and uses thereof |
| 09/18/2003 | WO2002014503A3 Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies |
| 09/18/2003 | US20030176688 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide |
| 09/18/2003 | US20030176672 Compositions and methods relating to breast specific genes and proteins |
| 09/18/2003 | US20030176670 Multivalent macrolide antibiotics |
| 09/18/2003 | US20030176665 Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them |
| 09/18/2003 | US20030176661 Novel antibody with specificity for colon cancer |
| 09/18/2003 | US20030176653 Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 09/18/2003 | US20030176647 Antibodies to OCIF-binding molecules |
| 09/18/2003 | US20030176382 Treatment of hookworm infection |
| 09/18/2003 | US20030176378 Vaccines and gene therapy compositions and methods of making and using the same |
| 09/18/2003 | US20030176377 DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof |
| 09/18/2003 | US20030176351 Peptides and peptide analogues designed from a diabetes-associated autoantigen, and methods for their use in the treatment and prevention of diabetes |
| 09/18/2003 | US20030176341 For use as an anti-viral, anti-tumour or immunomodulatory agent |
| 09/18/2003 | US20030176340 For therapy of renal failure |
| 09/18/2003 | US20030176336 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/18/2003 | US20030176332 Novel use of cytokine inhibitors |
| 09/18/2003 | US20030176331 Having therapeutic, diagnostic, and preventative benefits, particularly as immunotoxins; for therapy of cancer |
| 09/18/2003 | US20030175969 Prevention infant blood disorders |
| 09/18/2003 | US20030175960 Isolation, cloning of genes; anticancer agents, autoimmune disease; genetic engineered cells immobilized with hyaluronic acid |
| 09/18/2003 | US20030175921 Complexing antigen, antibodies; immunoassay |
| 09/18/2003 | US20030175900 Compositions and methods for the treatment of tumor |
| 09/18/2003 | US20030175887 Saturation mutagenesis in directed evolution |
| 09/18/2003 | US20030175884 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 09/18/2003 | US20030175881 Nucleic acids encoding (poly) peptides having chips activity |
| 09/18/2003 | US20030175876 a neurotrophin with biological activity on the central/peripheral nervous system cells; used for treating GDNF-responsive conditions such as alzhiemer's, parkinsons; device for nerve damage treatment |
| 09/18/2003 | US20030175863 Influenza immunogen and vaccine |
| 09/18/2003 | US20030175840 Kit which detects ligand associated with nuclear factor kappa beta receptor for treating toxic shock, sepsis, inflammation and graft vs host disease |
| 09/18/2003 | US20030175835 Gram-negative negative bacteria such as pasteurella trehalosi and/or mannheimia haemolytica for diagnosis and treatment of respiratory disorders in animals; veterinary medicine; genetic vaccines |
| 09/18/2003 | US20030175834 Polyphenol inhibition of nucleoside diphosphate kinase-B activity and cancer metastasis |
| 09/18/2003 | US20030175777 Plant extracts for induction/prevention of release of cytokines/chemokines; gene expression inhibition; for treating inflammation response/human immunodeficiency virus; heat shock proteins |
| 09/18/2003 | US20030175760 Identifying immunotoxin for treatment of cancers; antitumor/antiproliferative/anticarcinogenic agents |
| 09/18/2003 | US20030175731 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies |
| 09/18/2003 | US20030175725 Mycobacterial diagnostics |
| 09/18/2003 | US20030175715 Compositions and methods relating to breast specific genes and proteins |
| 09/18/2003 | US20030175711 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays |
| 09/18/2003 | US20030175707 Comprises nucleotide sequences coding prostate specific antigens for identifying, diagnosing, monitoring, staging, imaging and treating prostate cancer and non-cancerous disease in prostate tissue; drug screening; gene therapy |
| 09/18/2003 | US20030175700 Comprises nucleotide sequences coding chlamydia antigen for serodiagnosis and traetment of infection; genetic vaccines |